Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Natural killer (NK) cells are lymphocytes of the innate immunesystem that are involved in the early defenses against foreigncells, as well as autologous cells undergoing various formsof stress, such as microbial infection or tumor transformation.NK cell activation is controlled by a dynamic balance betweencomplementary and antagonistic pathways that are initiated uponinteraction with potential target cells. NK cells express anarray of activating cell surface receptors that can triggercytolytic programs, as well as cytokine or chemokine secretion.Some of these activating cell surface receptors initiate proteintyrosine kinase (PTK)dependent pathways through noncovalentassociations with transmembrane signaling adaptors that harborintracytoplasmic ITAMs (immunoreceptor tyrosine-based activationmotifs). Additional cell surface receptors that are not directlycoupled to ITAMs also participate in NK cell activation. Theseinclude NKG2D, which is noncovalently associated to the DAP10transmembrane signaling adaptor, as well as integrins and cytokinereceptors. NK cells also express cell surface inhibitory receptorsthat antagonize activating pathways through protein tyrosinephosphatases (PTPs). These inhibitory cell surface receptorsare characterized by intracytoplasmic ITIMs (immunoreceptortyrosine-based inhibition motifs). The tyrosine-phosphorylationstatus of several signaling components that are substrates forboth PTKs and PTPs is thus key to the propagation of the NKcell effector pathways. Understanding the integration of thesemultiple signals is central to the understanding and manipulationof NK cell effector signaling pathways.
1 Centre d'Immunologie de Marseille-Luminy, INSERMCNRSUniv. Méditerranée, Campus de Luminy, Case 906, 13288 Marseille cedex 09, France. 2 Institut de Cancérologie de Marseille, INSERM UMR 599, 13009 Marseille, France. 3 INSERM U608-Univ. Méditerranée, Faculté de Pharmacie, 13005 Marseille, France.
* To whom correspondence should be addressed. E-mail: vivier{at}ciml.univ-mrs.fr
The editors suggest the following Related Resources on Science sites:
In Science Magazine
INTRODUCTION TO SPECIAL ISSUE
L. Bryan Ray, Elizabeth M. Adler, and Nancy R. Gough (26 November 2004) Science306 (5701), 1505.
[DOI: 10.1126/science.306.5701.1505] |Summary »|PDF »
In Science Signaling
DATABASE OF CELL SIGNALING
Natural Killer Cell Receptor Signaling Pathway in Mice
Frédéric Vély, Paul J. Leibson and Eric Vivier Sci. Signal. (Connections Map Pathway), http://stke.sciencemag.org/cgi/cm/stkecm;CMP_14358 |Specific Pathway »
DATABASE OF CELL SIGNALING
Natural Killer Cell Receptor Signaling Pathway
Frédéric Vély and Eric Vivier Sci. Signal. (Connections Map Pathway), http://stke.sciencemag.org/cgi/cm/stkecm;CMP_13625 |Canonical Pathway »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Essential role of the Ly49A stalk region for immunological synapse formation and signaling.
D. Ito, Y.-M. Iizuka, M. P. Katepalli, and K. Iizuka (2009)
PNAS
106, 11264-11269
|Abstract »|Full Text »|PDF »
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.
J. Gertner-Dardenne, C. Bonnafous, C. Bezombes, A.-H. Capietto, V. Scaglione, S. Ingoure, D. Cendron, E. Gross, J.-F. Lepage, A. Quillet-Mary, et al. (2009)
Blood
113, 4875-4884
|Abstract »|Full Text »|PDF »
Creation of the two isoforms of rodent NKG2D was driven by a B1 retrotransposon insertion.
C. B. Lai, Y. Zhang, S. L. Rogers, and D. L. Mager (2009)
Nucleic Acids Res.
37, 3032-3043
|Abstract »|Full Text »|PDF »
Oxidative Stress Mediates a Reduced Expression of the Activating Receptor NKG2D in NK Cells from End-Stage Renal Disease Patients.
M.-N. Peraldi, J. Berrou, N. Dulphy, A. Seidowsky, P. Haas, N. Boissel, F. Metivier, C. Randoux, N. Kossari, A. Guerin, et al. (2009)
J. Immunol.
182, 1696-1705
|Abstract »|Full Text »|PDF »
Identification and Characterization of a Transmembrane Isoform of CD160 (CD160-TM), a Unique Activating Receptor Selectively Expressed upon Human NK Cell Activation.
J. Giustiniani, A. Bensussan, and A. Marie-Cardine (2009)
J. Immunol.
182, 63-71
|Abstract »|Full Text »|PDF »
NK cell-activating receptors require PKC-{theta} for sustained signaling, transcriptional activation, and IFN-{gamma} secretion.
I. Tassi, M. Cella, R. Presti, A. Colucci, S. Gilfillan, D. R. Littman, and M. Colonna (2008)
Blood
112, 4109-4116
|Abstract »|Full Text »|PDF »
Essential Role of DAP12 Signaling in Macrophage Programming into a Fusion-Competent State.
L. Helming, E. Tomasello, T. R. Kyriakides, F. O. Martinez, T. Takai, S. Gordon, and E. Vivier (2008)
Science Signaling
1, ra11
|Abstract »|Full Text »|PDF »
Inhibition of Mitogen-activated Protein Kinase Phosphatase 3 Activity by Interdomain Binding.
J. K. Mark, R. A. Aubin, S. Smith, and M. A. Hefford (2008)
J. Biol. Chem.
283, 28574-28583
|Abstract »|Full Text »|PDF »
Serum Supplementation Modulates the Effects of Dibutyltin on Human Natural Killer Cell Function.
M. M. Whalen, J. C. DeWitt, and R. W. Luebke (2008)
Toxicol. Sci.
104, 312-319
|Abstract »|Full Text »|PDF »
Cell Type-Specific Regulation of ITAM-Mediated NF-{kappa}B Activation by the Adaptors, CARMA1 and CARD9.
H. Hara, C. Ishihara, A. Takeuchi, L. Xue, S. W. Morris, J. M. Penninger, H. Yoshida, and T. Saito (2008)
J. Immunol.
181, 918-930
|Abstract »|Full Text »|PDF »
Dasatinib suppresses in vitro natural killer cell cytotoxicity.
S. J. Blake, A. Bruce Lyons, C. K. Fraser, J. D. Hayball, and T. P. Hughes (2008)
Blood
111, 4415-4416
|Full Text »|PDF »
Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN-{gamma} production.
S. Hidano, H. Sasanuma, K. Ohshima, K.-i. Seino, L. Kumar, K. Hayashi, M. Hikida, T. Kurosaki, M. Taniguchi, R. S. Geha, et al. (2008)
Int. Immunol.
20, 345-352
|Abstract »|Full Text »|PDF »
JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.
C. Li, B. Ge, M. Nicotra, J. N. H. Stern, H. D. Kopcow, X. Chen, and J. L. Strominger (2008)
PNAS
105, 3017-3022
|Abstract »|Full Text »|PDF »
WIP is essential for lytic granule polarization and NK cell cytotoxicity.
SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production.
M. Cho, K. Ishida, J. Chen, J. Ohkawa, W. Chen, S. Namiki, A. Kotaki, N. Arai, K.-i. Arai, and Y. Kamogawa-Schifter (2008)
Int. Immunol.
20, 155-164
|Abstract »|Full Text »|PDF »
EAE Tolerance Induction with Hsp70-Peptide Complexes Depends on H60 and NKG2D Activity.
G. Galazka, A. Jurewicz, W. Orlowski, M. Stasiolek, C. F. Brosnan, C. S. Raine, and K. Selmaj (2007)
J. Immunol.
179, 4503-4512
|Abstract »|Full Text »|PDF »
NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome.
R. Gazit, M. Aker, M. Elboim, H. Achdout, G. Katz, D. G. Wolf, S. Katzav, and O. Mandelboim (2007)
Blood
109, 4306-4312
|Abstract »|Full Text »|PDF »
FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection.
T. J. Wilson, R. M. Presti, I. Tassi, E. T. Overton, M. Cella, and M. Colonna (2007)
Blood
109, 3786-3793
|Abstract »|Full Text »|PDF »
Disparity in IL-12 Release in Dendritic Cells and Macrophages in Response to Mycobacterium tuberculosis Is Due to Use of Distinct TLRs.
L. Pompei, S. Jang, B. Zamlynny, S. Ravikumar, A. McBride, S. P. Hickman, and P. Salgame (2007)
J. Immunol.
178, 5192-5199
|Abstract »|Full Text »|PDF »
Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity.
X. Chen, P. P. Trivedi, B. Ge, K. Krzewski, and J. L. Strominger (2007)
PNAS
104, 6329-6334
|Abstract »|Full Text »|PDF »
CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
M. Rabot, H. El Costa, B. Polgar, A. Marie-Cardine, M. Aguerre-Girr, A. Barakonyi, S. Valitutti, A. Bensussan, and P. Le Bouteiller (2007)
Int. Immunol.
19, 401-409
|Abstract »|Full Text »|PDF »
Differential Regulation of Human NK Cell-Mediated Cytotoxicity by the Tyrosine Kinase Itk.
D. Khurana, L. N. Arneson, R. A. Schoon, C. J. Dick, and P. J. Leibson (2007)
J. Immunol.
178, 3575-3582
|Abstract »|Full Text »|PDF »
Dual Assemblies of an Activating Immune Receptor, MAIR-II, with ITAM-Bearing Adapters DAP12 and FcR{gamma} Chain on Peritoneal Macrophages.
C. Nakahashi, S. Tahara-Hanaoka, N. Totsuka, Y. Okoshi, T. Takai, N. Ohkohchi, S.-i. Honda, K. Shibuya, and A. Shibuya (2007)
J. Immunol.
178, 765-770
|Abstract »|Full Text »|PDF »
Segregation of HLA-C from ICAM-1 at NK Cell Immune Synapses Is Controlled by Its Cell Surface Density.
Differential and Nonredundant Roles of Phospholipase C{gamma}2 and Phospholipase C{gamma}1 in the Terminal Maturation of NK Cells.
J. Regunathan, Y. Chen, S. Kutlesa, X. Dai, L. Bai, R. Wen, D. Wang, and S. Malarkannan (2006)
J. Immunol.
177, 5365-5376
|Abstract »|Full Text »|PDF »
I. R. Turnbull, S. Gilfillan, M. Cella, T. Aoshi, M. Miller, L. Piccio, M. Hernandez, and M. Colonna (2006)
J. Immunol.
177, 3520-3524
|Abstract »|Full Text »|PDF »
Molecular and Functional Characterization of CD300b, a New Activating Immunoglobulin Receptor Able to Transduce Signals through Two Different Pathways..
Vav1 Controls DAP10-Mediated Natural Cytotoxicity by Regulating Actin and Microtubule Dynamics.
D. B. Graham, M. Cella, E. Giurisato, K. Fujikawa, A. V. Miletic, T. Kloeppel, K. Brim, T. Takai, A. S. Shaw, M. Colonna, et al. (2006)
J. Immunol.
177, 2349-2355
|Abstract »|Full Text »|PDF »
ADAP is dispensable for NK cell development and function.
L. V. Fostel, J. Dluzniewska, Y. Shimizu, B. J. Burbach, and E. J. Peterson (2006)
Int. Immunol.
18, 1305-1314
|Abstract »|Full Text »|PDF »
Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells.
M. Ferlito, K. Irani, N. Faraday, and C. J. Lowenstein (2006)
PNAS
103, 11689-11694
|Abstract »|Full Text »|PDF »
Microclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapses.
B. Treanor, P. M.P. Lanigan, S. Kumar, C. Dunsby, I. Munro, E. Auksorius, F. J. Culley, M. A. Purbhoo, D. Phillips, M. A.A. Neil, et al. (2006)
J. Cell Biol.
174, 153-161
|Abstract »|Full Text »|PDF »
Effects of adenylyl cyclase and protein kinase A inhibition on signaling enzymes in natural killer cells: comparison to tributyltin.
M M Whalen and S O Odman-Ghazi (2006)
Human and Experimental Toxicology
25, 333-340
|Abstract »|PDF »
Multiplicity and plasticity of natural killer cell signaling pathways.
S. Chiesa, M. Mingueneau, N. Fuseri, B. Malissen, D. H. Raulet, M. Malissen, E. Vivier, and E. Tomasello (2006)
Blood
107, 2364-2372
|Abstract »|Full Text »|PDF »
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
A. L. Blasius, M. Cella, J. Maldonado, T. Takai, and M. Colonna (2006)
Blood
107, 2474-2476
|Abstract »|Full Text »|PDF »
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.
K. Suzuki-Inoue, G. L. J. Fuller, A. Garcia, J. A. Eble, S. Pohlmann, O. Inoue, T. K. Gartner, S. C. Hughan, A. C. Pearce, G. D. Laing, et al. (2006)
Blood
107, 542-549
|Abstract »|Full Text »|PDF »
Silencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells.
M. Karimi, T. M. Cao, J. A. Baker, M. R. Verneris, L. Soares, and R. S. Negrin (2005)
J. Immunol.
175, 7819-7828
|Abstract »|Full Text »|PDF »
The Cytotoxicity Receptor CRACC (CS-1) Recruits EAT-2 and Activates the PI3K and Phospholipase C{gamma} Signaling Pathways in Human NK Cells.
Heterogeneous Human NK Cell Responses to Plasmodium falciparum-Infected Erythrocytes.
D. S. Korbel, K. C. Newman, C. R. Almeida, D. M. Davis, and E. M. Riley (2005)
J. Immunol.
175, 7466-7473
|Abstract »|Full Text »|PDF »
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-{beta}-dependent manner.
F. Ghiringhelli, C. Menard, M. Terme, C. Flament, J. Taieb, N. Chaput, P. E. Puig, S. Novault, B. Escudier, E. Vivier, et al. (2005)
J. Exp. Med.
202, 1075-1085
|Abstract »|Full Text »|PDF »
Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44.
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.
C. A. Stewart, F. Laugier-Anfossi, F. Vely, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagne, G. Ferracci, F. A. Arosa, et al. (2005)
PNAS
102, 13224-13229
|Abstract »|Full Text »|PDF »
DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis.
I. R. Turnbull, J. E. McDunn, T. Takai, R. R. Townsend, J. P. Cobb, and M. Colonna (2005)
J. Exp. Med.
202, 363-369
|Abstract »|Full Text »|PDF »
Phospholipase C-{gamma}2 Is a Critical Signaling Mediator for Murine NK Cell Activating Receptors.
I. Tassi, R. Presti, S. Kim, W. M. Yokoyama, S. Gilfillan, and M. Colonna (2005)
J. Immunol.
175, 749-754
|Abstract »|Full Text »|PDF »
The Isoforms of Phospholipase C-{gamma} Are Differentially Used by Distinct Human NK Activating Receptors.
J. L. Upshaw, R. A. Schoon, C. J. Dick, D. D. Billadeau, and P. J. Leibson (2005)
J. Immunol.
175, 213-218
|Abstract »|Full Text »|PDF »
The Chicken Leukocyte Receptor Complex: A Highly Diverse Multigene Family Encoding at Least Six Structurally Distinct Receptor Types.
B. C. Viertlboeck, F. A. Habermann, R. Schmitt, M. A. M. Groenen, L. Du Pasquier, and T. W. Gobel (2005)
J. Immunol.
175, 385-393
|Abstract »|Full Text »|PDF »
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues.
Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.
M. Carrington, S. Wang, M. P. Martin, X. Gao, M. Schiffman, J. Cheng, R. Herrero, A. C. Rodriguez, R. Kurman, R. Mortel, et al. (2005)
J. Exp. Med.
201, 1069-1075
|Abstract »|Full Text »|PDF »